We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-16.68%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$63B
AUM Growth
-$15.8B
Cap. Flow
-$523M
Cap. Flow %
-0.83%
Top 10 Hldgs %
24.77%
Holding
3,865
New
199
Increased
1,422
Reduced
1,761
Closed
372

Top Buys

Rank Stock Value
1
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$220M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$117M
3
AMZN icon
Amazon
AMZN
+$106M
4
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$80.8M
5
ICSH icon
iShares Ultra Short Duration Bond Active ETF
ICSH
+$67.1M

Top Sells

Rank Stock Value
1
CCL icon
Carnival Corporation Ltd
CCL
+$106M
2
CNK icon
Cinemark Holdings
CNK
+$61.6M
3
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$56.3M
4
OXY icon
Occidental Petroleum
OXY
+$55.9M
5
TTE icon
TotalEnergies
TTE
+$51.3M

Sector Composition

Rank Sector Weight
1 Technology 12.16%
2 Healthcare 9.23%
3 Financials 8.29%
4 Industrials 5.85%
5 Communication Services 5.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HTZ
3251
DELISTED
Hertz Global Holdings, Inc.
HTZ
$65K ﹤0.01%
+10,517
New +$142K
PVL
3252
Permianville Royalty Trust
PVL
$58.1M
$64K ﹤0.01%
60,400
– –
KDNY
3253
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$64K ﹤0.01%
4,690
– –
ADT icon
3254
ADT
ADT
$5.46B
$63K ﹤0.01%
14,473
-39,865
-73% -$241K
HBM icon
3255
Hudbay
HBM
$11.8B
$63K ﹤0.01%
33,477
+10,113
+43% +$28K
RCEL icon
3256
Avita Medical
RCEL
$248M
$63K ﹤0.01%
+2,032
New +$84.1K
XCUR icon
3257
Exicure
XCUR
$8.35M
$63K ﹤0.01%
283
+83
+42% +$26.3K
ALDX icon
3258
Aldeyra Therapeutics
ALDX
$86.9M
$61K ﹤0.01%
24,600
+2,000
+9% +$8.99K
DCH
3259
Dauch Corp
DCH
$1.6B
$61K ﹤0.01%
16,817
+738
+5% +$5.49K
IVR icon
3260
Invesco Mortgage Capital
IVR
$805M
$61K ﹤0.01%
1,775
-553
-24% -$81.2K
NXE icon
3261
NexGen Energy
NXE
$6.97B
$61K ﹤0.01%
79,153
-4,500
-5% -$4.48K
JNCE
3262
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$61K ﹤0.01%
+12,932
New +$74.4K
EXEL icon
3263
CALL
Exelixis
EXEL
$12.5B
$59K ﹤0.01%
+34,600
New +$633K
NCV
3264
Virtus Convertible & Income Fund
NCV
$390M
$59K ﹤0.01%
3,957
-588
-13% -$12.4K
PHK
3265
PIMCO High Income Fund
PHK
$865M
$59K ﹤0.01%
12,101
-2,141
-15% -$14.6K
AMSC icon
3266
American Superconductor
AMSC
$1.53B
$58K ﹤0.01%
10,500
– –
MAC icon
3267
Macerich
MAC
$6.99B
$58K ﹤0.01%
10,253
-8,004
-44% -$159K
ADAP
3268
DELISTED
Adaptimmune Therapeutics
ADAP
$57K ﹤0.01%
20,801
-8,610
-29% -$28.6K
PFE icon
3269
CALL
Pfizer
PFE
$153B
$56K ﹤0.01%
228,191
+14,967
+7% +$510K
NGD
3270
DELISTED
New Gold Inc
NGD
$55K ﹤0.01%
106,933
-59,388
-36% -$48K
GALT icon
3271
Galectin Therapeutics
GALT
$356M
$54K ﹤0.01%
27,740
– –
TT icon
3272
CALL
Trane Technologies
TT
$105B
$54K ﹤0.01%
21,200
-18,700
-47% -$2.27M
QTNT
3273
DELISTED
Quotient Limited Ordinary Shares
QTNT
$54K ﹤0.01%
342
+68
+25% +$17.8K
ATEC icon
3274
Alphatec Holdings
ATEC
$1.51B
$53K ﹤0.01%
+15,506
New +$89.1K
TGS icon
3275
Transportadora de Gas del Sur
TGS
$4.2B
$53K ﹤0.01%
11,423
-521
-4% -$3.04K
129 130
131
132 133

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q1 2020 Portfolio in Review

As of Q1 2020, Raymond James & Associates held 3,865 positions worth $63B, down 20% from $78.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Raymond James & Associates's Q1 2020 filing shows 199 new, 1,422 increased, 1,761 reduced and 372 closed positions. Its largest new stake was BlackRock Health Sciences Trust II: 570,215 shares worth $10.2M. The largest sale was Carnival Corporation Ltd, an estimated $106M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q1 2020 buy was BlackRock Health Sciences Trust II: 570,215 shares worth $10.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q1 2020, an estimated $220M increase.
  • Raymond James & Associates's biggest Q1 2020 reduction was Carnival Corporation Ltd, cutting an estimated $106M.
  • Raymond James & Associates fully exited State Street SPDR Portfolio S&P 400 Mid Cap ETF in Q1 2020, selling an estimated $36.8M.
  • Raymond James & Associates's ten largest holdings make up 25% of its $63B portfolio in Q1 2020.
  • Raymond James & Associates opened 199 new positions and closed 372 in Q1 2020.
  • Raymond James & Associates's portfolio value fell 20% quarter-over-quarter to $63B.

Based on Raymond James & Associates's 13F filing for Q1 2020, filed 21 Apr 2020.